Delic Holdings Corp has announced that its subsidiary, Delic Labs, received a Health Canada 56 Research Exemption that will allow scientists to conduct research and perform tests on a number of compounds outside of psychedelic mushrooms, including MDMA, LSD, DMT, mescaline and 2C-B. Additionally, Delic Labs has received a Health Canada 56 exemption to acquire 60 grams of psilocybin mushrooms from Nectar Health Sciences Laboratory Division.
Category Press Release
Published in Cision
Companies Featured
Delic CorpDelic is a psychedelic wellness corporation committed to bringing safe, legal and science-backed benefits of psychedelics to all. Delic consists of clinics, media outlets and research facilities which educate, influence and deliver wellness solutions at scale.
Delic Labs
Delic Labs is a licensed cannabis and psilocybin research laboratory with a focus on extraction optimization, analytical testing, and chemical process development to advance the psychedelic-wellness industry. Formerly known as Complex Biotech Discovery Ventures, the company was acquired by Delic Corp in February 2021.